Development of Anti-Human Mesothelin-Targeted Chimeric Antigen Receptor Messenger RNA–Transfected Peripheral Blood Lymphocytes for Ovarian Cancer Therapy
-
- Chien-Fu Hung
- Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland
-
- Xuequn Xu
- Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland
-
- Linhong Li
- MaxCyte, Inc., Gaithersburg, Maryland
-
- Ying Ma
- Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland
-
- Qiu Jin
- Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland
-
- Angelia Viley
- MaxCyte, Inc., Gaithersburg, Maryland
-
- Cornell Allen
- MaxCyte, Inc., Gaithersburg, Maryland
-
- Pachai Natarajan
- MaxCyte, Inc., Gaithersburg, Maryland
-
- Rama Shivakumar
- MaxCyte, Inc., Gaithersburg, Maryland
-
- Madhusudan V. Peshwa
- MaxCyte, Inc., Gaithersburg, Maryland
-
- Leisha A. Emens
- Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland
Journal
-
- Human Gene Therapy
-
Human Gene Therapy 29 (5), 614-625, 2018-05
Mary Ann Liebert Inc
- Tweet
Details 詳細情報について
-
- CRID
- 1361981468774640128
-
- ISSN
- 15577422
- 10430342
-
- Data Source
-
- Crossref